Copyright Reports & Markets. All rights reserved.

Global Acute Migraine Treatments Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Acute Migraine Treatments Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Drugs
      • 1.4.3 Patches
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Acute Migraine Treatments Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Drug Stores
      • 1.5.4 Retail Pharmacies
      • 1.5.5 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Acute Migraine Treatments Market Size
    • 2.2 Acute Migraine Treatments Growth Trends by Regions
      • 2.2.1 Acute Migraine Treatments Market Size by Regions (2014-2025)
      • 2.2.2 Acute Migraine Treatments Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Acute Migraine Treatments Market Size by by Players
      • 3.1.1 Global Acute Migraine Treatments Revenue by by Players (2014-2019)
      • 3.1.2 Global Acute Migraine Treatments Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Acute Migraine Treatments Market Concentration Ratio (CR5 and HHI)
    • 3.2 Acute Migraine Treatments Key Players Head office and Area Served
    • 3.3 Key Players Acute Migraine Treatments Product/Solution/Service
    • 3.4 Date of Enter into Acute Migraine Treatments Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Acute Migraine Treatments Market Size by Type (2014-2019)
    • 4.2 Global Acute Migraine Treatments Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Acute Migraine Treatments Market Size (2014-2019)
    • 5.2 Acute Migraine Treatments Key Players in United States
    • 5.3 United States Acute Migraine Treatments Market Size by Type
    • 5.4 United States Acute Migraine Treatments Market Size by Application

    6 Europe

    • 6.1 Europe Acute Migraine Treatments Market Size (2014-2019)
    • 6.2 Acute Migraine Treatments Key Players in Europe
    • 6.3 Europe Acute Migraine Treatments Market Size by Type
    • 6.4 Europe Acute Migraine Treatments Market Size by Application

    7 China

    • 7.1 China Acute Migraine Treatments Market Size (2014-2019)
    • 7.2 Acute Migraine Treatments Key Players in China
    • 7.3 China Acute Migraine Treatments Market Size by Type
    • 7.4 China Acute Migraine Treatments Market Size by Application

    8 Japan

    • 8.1 Japan Acute Migraine Treatments Market Size (2014-2019)
    • 8.2 Acute Migraine Treatments Key Players in Japan
    • 8.3 Japan Acute Migraine Treatments Market Size by Type
    • 8.4 Japan Acute Migraine Treatments Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Acute Migraine Treatments Market Size (2014-2019)
    • 9.2 Acute Migraine Treatments Key Players in Southeast Asia
    • 9.3 Southeast Asia Acute Migraine Treatments Market Size by Type
    • 9.4 Southeast Asia Acute Migraine Treatments Market Size by Application

    10 India

    • 10.1 India Acute Migraine Treatments Market Size (2014-2019)
    • 10.2 Acute Migraine Treatments Key Players in India
    • 10.3 India Acute Migraine Treatments Market Size by Type
    • 10.4 India Acute Migraine Treatments Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Acute Migraine Treatments Market Size (2014-2019)
    • 11.2 Acute Migraine Treatments Key Players in Central & South America
    • 11.3 Central & South America Acute Migraine Treatments Market Size by Type
    • 11.4 Central & South America Acute Migraine Treatments Market Size by Application

    12 International Players Profiles

    • 12.1 Amgen
      • 12.1.1 Amgen Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Acute Migraine Treatments Introduction
      • 12.1.4 Amgen Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.1.5 Amgen Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Acute Migraine Treatments Introduction
      • 12.2.4 Pfizer Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Acute Migraine Treatments Introduction
      • 12.3.4 Novartis Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Eli Lily
      • 12.4.1 Eli Lily Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Acute Migraine Treatments Introduction
      • 12.4.4 Eli Lily Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.4.5 Eli Lily Recent Development
    • 12.5 AstraZeneca
      • 12.5.1 AstraZeneca Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Acute Migraine Treatments Introduction
      • 12.5.4 AstraZeneca Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.5.5 AstraZeneca Recent Development
    • 12.6 Teva Pharmaceutical
      • 12.6.1 Teva Pharmaceutical Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Acute Migraine Treatments Introduction
      • 12.6.4 Teva Pharmaceutical Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.6.5 Teva Pharmaceutical Recent Development
    • 12.7 Allergan
      • 12.7.1 Allergan Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Acute Migraine Treatments Introduction
      • 12.7.4 Allergan Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.7.5 Allergan Recent Development
    • 12.8 Abbott
      • 12.8.1 Abbott Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Acute Migraine Treatments Introduction
      • 12.8.4 Abbott Revenue in Acute Migraine Treatments Business (2014-2019)
      • 12.8.5 Abbott Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A migraine is an episodic and unpredictable headache disorder that presents with disabling attacks. Treatment of a migraine attack should be guided by response to previous treatment and the severity of the attacks.
      In 2018, the global Acute Migraine Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Acute Migraine Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Migraine Treatments development in United States, Europe and China.

      The key players covered in this study
      Amgen
      Pfizer
      Novartis
      Eli Lily
      AstraZeneca
      Teva Pharmaceutical
      Allergan
      Abbott

      Market segment by Type, the product can be split into
      Drugs
      Patches
      Others

      Market segment by Application, split into
      Hospital Pharmacies
      Drug Stores
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Acute Migraine Treatments status, future forecast, growth opportunity, key market and key players.
      To present the Acute Migraine Treatments development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Acute Migraine Treatments are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now